N/A N=99 Randomized Single-blind Treatment

Nasal Intubation Using King Vision Video Laryngoscopy

Nasal Intubation

Bottom Line

View on ClinicalTrials.gov: NCT03126344 ↗

Enrolled (actual)

Serious AEs

0.0%

Results posted

Sep 2020

Primary outcome: Primary: Time to Intubation — 37.6; 35.4; 46.8 second

Study Design & Population

Study type: Interventional
Phase: N/A
Interventions: King Vision video laryngoscope (Device); McGrath MAC video laryngoscope (Device); Macintosh laryngoscope (Device)
Age: Adult · 18+ yrs
Sex: All
Sponsor: Shanghai Ninth People's Hospital Affiliated to Shanghai Jiao Tong University
Primary completion: Jan 2018

Outcome Measures

Outcome	Result	p-value
PRIMARY Time to Intubation	37.6; 35.4; 46.8	—
SECONDARY Laryngoscopy Time	16.7; 15.6; 22.8	—
SECONDARY Number of Participants With Complications	6; 7; 21	—

Summary

This study was designed to determine the comparison between the King Vision video laryngoscope 、 McGrath MAC video laryngoscope and Macintosh laryngoscope for nasotracheal intubation.Patients were divided into 3 groups of 30 patients each.Patients of King Vision group [n=30]、 McGrath MAC group [n=30] and Macintosh group[n=30]were intubated using respective devices.This study is the first to search the use of King Vision video laryngoscope for nasotracheal intubation.

Eligibility Criteria

Inclusion Criteria

ASA physical status 1-2
general anesthesia with nasotracheal intubation
anticipated difficult airway

Exclusion Criteria

contraindications to nasal intubation
Patients with a history of anti-hypertensive drugs

View full record on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov (NCT03126344). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.